Jeffrey J. Kimbell & Associates provides legislative solutions to clients in the healthcare community facing issues related to product approval, coverage and reimbursement, marketing practices, and more. Founded in 1998, Kimbell & Associates has since grown to include five full-time lobbyists and/or policy experts in the life sciences field, including medical devices, pharmaceuticals biotechnology, provider services, and biodefense. Currently, the firm represents 19 selected clients, all of which reside in the life sciences area.
The firm’s expertise focuses on the executive and legislative branches of the U.S. federal government and specializes in providing strategic solutions to a select group of healthcare sector clients seeking creation, modification, or proper implementation of public law. Through active lobbying on Capitol Hill, as well as working with the relevant federal healthcare agencies, Kimbell & Associates can dismantle the roadblocks that obstruct an organization’s ability to deliver technologies and services to their patients. The firm currently lobbies on behalf of clients with issues before the U.S. Department of Health & Human Services, the U.S. Department of Commerce, the U.S. Department of Homeland Security, and the U.S. Department of Defense. The firm maintains strong relationships with political appointees and policy teams in cabinet-level departments, agencies, and sub-agencies. The firm’s principals have more than 30 years of experience working with the Congressional committees with oversight and budget authority over the various federal departments including the House and Senate Appropriations Committees, the House Ways & Means Committee, the House Energy & Commerce Committee, the Senate Finance Committee and the Senate Health, Education, Labor & Pensions Committee.
The health policy team at Kimbell & Associates is a fully integrated component of the regulatory services offered to our clients. Our staff has extensive experience cultivating strategies that address long term opportunities and challenges, including value-based purchasing, comparative effectiveness research, and quality reporting. By constantly monitoring and analyzing health policy activity related to life sciences companies, we are immediately cognizant of regulatory developments and work directly with agency officials to ensure that our clients’ interests are considered. In addition, our coding, coverage and payment experts develop successful reimbursement plans for new and existing products that achieve optimal positioning in the marketplace.
With backgrounds in both the private and public sectors, the firm’s principals leverage institutional knowledge and valued relationships as former staff to Congressional Members and Governors, Administration appointees, and private sector analysts on behalf of our clients. Each principal has played a pivotal role in developing policy and affecting the legislative agendas on some of the most critical domestic policy issues, including those related to Medicare, Medicaid, private sector healthcare, medical liability reform, and the Food and Drug Administration. Our principals’ experience enables the firm to advocate for and protect our clients’ interests by identifying, accessing, and educating key officials in the healthcare sector.